Clinical Trial Update: Use of the MiCK Assay for Apoptosis in AML

View source ↗

Summary

An update on a clinical trial evaluating the MiCK assay for apoptosis in acute myeloid leukemia. The document summarizes the trial status and outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Pierian Biosciences | Conditions: Leukemia, Myelocytic, Acute | Status: COMPLETED